Veranstaltungen

Beginn:

20. April 2023

Ende:

22. April 2023

Ort/Raum:

Steintor-Varieté Halle (Saale)
Am Steintor 10
06112 Halle
Foyer

Veranstalter :

Institut für Medizinische Immunologie , Organizer of the conference is the German Society for Immunology e.V. (DGfI). In her functions as head of the DGfI working group on tumor immunology and former director of the Institute of Medical Immunology, Prof. Dr. Seliger realizes this event at the Steintor-Varieté Halle (Saale).

The meeting „Tumor Immunology meets Oncology (TIMO)“ has established itself as an outstanding platform for exchange between scientists, clinicians and junior staff and as one of the leading European conferences in the field of tumor immunology. From 20-22 April 2023, the meeting will happen for the 17th time at the Steintor Varieté Halle (Saale).

The symposium takes place over three days and begins with a workshop that enables young scientists to present their own data in a short lecture. The latest methods and techniques in the field of tumor treatment will also be presented. The accompanying poster exhibition facilitates discussion of further projects and the establishment of new cooperations. Following the workshop, we will award prizes for the three best lectures and posters. The scientific program will be rounded off with a networking evening on Friday allowing the discussion of projects and experiments in a relaxed atmosphere.

On the following two days, the established and renowned scientists will have their say. An overview:

Prof. Hinrich Abken (Regensburg, GER)

CARs become CHIC: cytokine help intensified CAR T cells

Prof. Achim Aigner (Leipzig, GER)

Nanoparticle-based delivery of nucleic acids in tumor and immune cells

Prof. Michael Bachmann (Dresden, GER)

Modular Immunotargeting

Prof. Mascha Binder (Basel, CH)

Biomarkers in IO trials for solid tumors

Prof. Martin Bornhäuser (Dresden, GER)

Current limitations of immunotherapeutic approaches in AML

Prof. Vincenzo Bronte (Padova, ITA)

Neutrophil extracellular traps restrain anti-tumor T cell activity in pancreatic cancer

Dr. Aitziber Buqué Martinez (New York, USA)

Conditioning TME metabolism to improve radiation and endocrine-based therapies

Prof. Angus Dalgleish (London, GBR)

Harvesting the anti-tumour activity of Vγ9Vδ2 T cells in cancer immunotherapy

Prof. Sandra Demaria (New York, USA)

Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors

Dr. Noel de Miranda (Leiden, NL)

New players in colorectal cancer immunity: beyond (conventional) T cells

Prof. Bernard Fox (Portland, USA)

Peptidomics and immunotherapy

Prof. Lorenzo Galluzzi (New York, USA)

Harnessing radiotherapy to unlock the full potential of cancer immunotherapy

Prof. Stefan Glück (Miami, USA)

Patients are waiting - the promise of immune oncology for 2023 and beyond

Prof. Hubert Hackl (Innsbruck, AUT)

Immunogenomic analyses reveal vulnerability for combination immunotherapy in ovarian cancer

Prof. Stefano Indraccolo (Padova, ITA)

Liquid biopsy to track therapeutic and adverse effects of immunotherapy in lung cancer patients

Prof. Markus Maeurer (Lissabon, PRT)

Cellular immune responses directed against pancreatic cancer: the trilogy of AB-, GD- and MAIT-T-cells

Prof. Michele Maio (Siena, ITA)

Epigenetics and melanoma

Prof. Ofer Mandelboim (Jerusalem, ISR)

Fusubacterium nucleatum: from tooth to tumors

Prof. Sergio Rutella (Nottingham, GBR)

Clinical implications of T cell dysfunctional states in acute myeloid leukaemia

Prof. Barbara Seliger (Halle, Brandenburg, GER)

Non-coding RNAs as regulators of the tumor immune escape and therapeutic targets in tumors

Stina Wickström (Stockhom, SWE)

Improving ACT therapy through combination with a DC tumor vaccine and protecting NK cells and T cells against oxidative stress

Prof. Qing Yang (Fudan, CHN)

Role and clinical relevance of indoleamine 2‘3‘ dioxygenase in tumors

The meeting is made possible by the great commitment of the members of the Institute of Medical Immunology of the Martin Luther University Halle-Wittenberg, the support of the German Society of Immunology (DGfI), the Society of Immunotherapy in Cancer (SITC) and its staff as well as the commitment of numerous sponsors. We are looking forward to another exciting event in 2023!

Schedule of the meeting 2023

Thursday, 20th of April 2023:

WORKSHOP

Start: 12.00 a.m.

End: 5.30 p.m.

Poster Session: 05.30-7.00 p.m.

Speakers: students, postdocs, young professionals, spin offs

Friday, 21st of April 2023:

MAIN SYMPOSIUM

Start: 8.30 a.m.

End: 6.00 p.m.

Speakers: professionals, clinicians, researchers

Networking event/ dinner for ALL: 8.00 p.m. in Halle (Saale), Steintor-Varieté

Saturday, 22nd of April 2023:

MAIN SYMPOSIUM

Start: 8.30 a.m.

End: 1.00 p.m.

Speakers: professionals, clinicians, researchers

Registration fee:

300 € (regular)
200 € (Ph students)
100 € (external BSc/MSc students and employees of the MLU)
0 € (students of the MLU)

Please register via the registration link at the homepage of the German Society of Immunology:

https://dgfi.org/arbeitskreise/ak-tumorimmunologie/meeting/

News will follow!